- Home
- EVOK vs LGHL Comparison
EVOK vs LGHL Comparison
Compare EVOK & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- LGHL
- Stock Information
- Founded
- EVOK 2007
- LGHL 2015
- Country
- EVOK United States
- LGHL Singapore
- Employees
- EVOK N/A
- LGHL N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- EVOK Health Care
- LGHL Finance
- Exchange
- EVOK Nasdaq
- LGHL Nasdaq
- Market Cap
- EVOK 4.2M
- LGHL 4.3M
- IPO Year
- EVOK 2013
- LGHL N/A
- Fundamental
- Price
- EVOK $2.45
- LGHL $3.18
- Analyst Decision
- EVOK
- LGHL
- Analyst Count
- EVOK 0
- LGHL 0
- Target Price
- EVOK N/A
- LGHL N/A
- AVG Volume (30 Days)
- EVOK 27.3K
- LGHL 61.8K
- Earning Date
- EVOK 03-13-2025
- LGHL 04-29-2025
- Dividend Yield
- EVOK N/A
- LGHL N/A
- EPS Growth
- EVOK N/A
- LGHL N/A
- EPS
- EVOK N/A
- LGHL N/A
- Revenue
- EVOK $10,249,415.00
- LGHL $13,659,110.00
- Revenue This Year
- EVOK $99.03
- LGHL N/A
- Revenue Next Year
- EVOK $60.15
- LGHL N/A
- P/E Ratio
- EVOK N/A
- LGHL N/A
- Revenue Growth
- EVOK 97.84
- LGHL 11.24
- 52 Week Low
- EVOK $2.40
- LGHL $2.82
- 52 Week High
- EVOK $12.32
- LGHL $43.00
- Technical
- Relative Strength Index (RSI)
- EVOK 26.36
- LGHL 28.86
- Support Level
- EVOK $2.51
- LGHL $2.82
- Resistance Level
- EVOK $2.81
- LGHL $3.69
- Average True Range (ATR)
- EVOK 0.29
- LGHL 0.62
- MACD
- EVOK -0.02
- LGHL -0.07
- Stochastic Oscillator
- EVOK 8.12
- LGHL 6.72
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.